Brooklyn ImmunoTherapeutics Announces Fourth Quarter and
SAN DIEGO, April 15, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn”), a biopharmaceutical company focused on...
Source: globenewswire.com
📰 Jay Sial News
Jay Sial News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jay Sial. Real-time updates on events, politics, business and more.